Canada's Generex Biotechnology Corp says that the Ministry of Health of the United Arab Emirates' Drugs Control Department has issued a non-objection letter to the Imperial College London Diabetes Centre to import Generex Oral-lyn, its proprietary oral insulin spray product, into Abu Dhabi.
The Manager of the Drugs Control Department indicated that importation of the firm's Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze